Johnson Matthey PLC (LON:JMAT – Get Free Report) reached a new 52-week low during trading on Friday . The company traded as low as GBX 1,312 ($16.02) and last traded at GBX 1,312 ($16.02), with a volume of 487292 shares trading hands. The stock had previously closed at GBX 1,340 ($16.36).
Analysts Set New Price Targets
Several research firms recently issued reports on JMAT. Berenberg Bank dropped their target price on shares of Johnson Matthey from GBX 1,650 ($20.15) to GBX 1,500 ($18.32) and set a “hold” rating on the stock in a report on Thursday, November 28th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 1,800 ($21.98) price objective on shares of Johnson Matthey in a research note on Tuesday, December 17th.
Check Out Our Latest Research Report on JMAT
Johnson Matthey Price Performance
Johnson Matthey Cuts Dividend
The business also recently declared a dividend, which will be paid on Tuesday, February 4th. Investors of record on Thursday, December 5th will be issued a GBX 22 ($0.27) dividend. The ex-dividend date of this dividend is Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey’s dividend payout ratio (DPR) is presently 13,275.86%.
Insiders Place Their Bets
In related news, insider Liam Condon acquired 27 shares of the firm’s stock in a transaction that occurred on Wednesday, October 16th. The shares were bought at an average cost of GBX 1,505 ($18.38) per share, for a total transaction of £406.35 ($496.15). Also, insider Stephen Oxley bought 7,407 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was bought at an average price of GBX 1,343 ($16.40) per share, with a total value of £99,476.01 ($121,460.33). Insiders bought 7,458 shares of company stock valued at $10,024,332 over the last ninety days. 0.61% of the stock is currently owned by insiders.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- Consumer Discretionary Stocks Explained
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- 10 Best Airline Stocks to Buy
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.